1. Home
  2. DOMH vs ATYR Comparison

DOMH vs ATYR Comparison

Compare DOMH & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dominari Holdings Inc.

DOMH

Dominari Holdings Inc.

HOLD

Current Price

$2.20

Market Cap

53.1M

Sector

Health Care

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.43

Market Cap

49.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOMH
ATYR
Founded
1967
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.1M
49.2M
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
DOMH
ATYR
Price
$2.20
$0.43
Analyst Decision
Hold
Analyst Count
0
9
Target Price
N/A
$3.67
AVG Volume (30 Days)
154.3K
605.1K
Earning Date
05-12-2026
05-01-2026
Dividend Yield
23.45%
N/A
EPS Growth
34.03
6.98
EPS
N/A
N/A
Revenue
$123,104,000.00
$190,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
578.41
N/A
52 Week Low
$1.91
$0.40
52 Week High
$8.40
$6.50

Technical Indicators

Market Signals
Indicator
DOMH
ATYR
Relative Strength Index (RSI) 31.05 34.21
Support Level N/A $0.40
Resistance Level $3.29 $0.59
Average True Range (ATR) 0.12 0.04
MACD -0.05 -0.01
Stochastic Oscillator 12.82 0.14

Price Performance

Historical Comparison
DOMH
ATYR

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc is a holding company that, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading, asset management, and insurance. In addition to capital investment, Dominari provides management support to the executive teams of its subsidiaries, helping them to operate efficiently and reduce costs under a streamlined infrastructure. The Company operates in two reportable business segments: Dominari Financial and Legacy AIkido, with the majority of revenue from Dominari Financial.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: